tetano
Editor, Senior Moderator
J Prim Care Community Health
. Jan-Dec 2021;12:21501327211007020.
doi: 10.1177/21501327211007020.
The Development of a Novel Outpatient Infusion Therapy Center for Treatment of COVID-19 in a Rural Healthcare System
Edward Malone[SUP] 1 [/SUP], Joseph Krien[SUP] 1 [/SUP], Betty Jorgenson[SUP] 1 [/SUP], Rachel Bishop[SUP] 1 [/SUP], Jenny Tempelis[SUP] 1 [/SUP], Mary Gilmer[SUP] 1 [/SUP], David Ring[SUP] 1 [/SUP], Heather Kujak-Coon[SUP] 1 [/SUP], Andrew Jagim[SUP] 1 [/SUP]
Affiliations
Abstract
Therapeutic interventions to manage symptoms of COVID-19 are continually evolving and being used in a variety of settings. In an attempt to reduce the potential for a high influx of hospital admissions for COVID-19 and mitigate the advancement of COVID-19 disease in infected patients, an outpatient therapy clinic for infusion therapy was established. The focus of the current paper is to outline the development of the outpatient treatment center, provide a detailed summary of workflow and discuss operational challenges and directions for the future.
Keywords: COVID-19; coronavirus; monoclonal antibodies; outpatient therapy; pandemic.
. Jan-Dec 2021;12:21501327211007020.
doi: 10.1177/21501327211007020.
The Development of a Novel Outpatient Infusion Therapy Center for Treatment of COVID-19 in a Rural Healthcare System
Edward Malone[SUP] 1 [/SUP], Joseph Krien[SUP] 1 [/SUP], Betty Jorgenson[SUP] 1 [/SUP], Rachel Bishop[SUP] 1 [/SUP], Jenny Tempelis[SUP] 1 [/SUP], Mary Gilmer[SUP] 1 [/SUP], David Ring[SUP] 1 [/SUP], Heather Kujak-Coon[SUP] 1 [/SUP], Andrew Jagim[SUP] 1 [/SUP]
Affiliations
- PMID: 33771055
- DOI: 10.1177/21501327211007020
Abstract
Therapeutic interventions to manage symptoms of COVID-19 are continually evolving and being used in a variety of settings. In an attempt to reduce the potential for a high influx of hospital admissions for COVID-19 and mitigate the advancement of COVID-19 disease in infected patients, an outpatient therapy clinic for infusion therapy was established. The focus of the current paper is to outline the development of the outpatient treatment center, provide a detailed summary of workflow and discuss operational challenges and directions for the future.
Keywords: COVID-19; coronavirus; monoclonal antibodies; outpatient therapy; pandemic.